Voyager Therapeutics Executives Sell 33,097 Shares Amid Market Volatility
ByAinvest
Thursday, Feb 26, 2026 9:59 am ET1min read
VYGR--
Voyager Therapeutics, Inc. (VYGR) has recently announced that Chief Scientific Officer Carter Todd Alfred sold 4,174 shares at $3.76 per share on February 24, 2026. Similarly, Chief Financial Officer Nathan D. Jorgensen sold 4,668 shares at $3.77 per share on the same day. Additionally, President and CEO Alfred Sandrock sold 14,197 shares at $3.79 per share, while COO and CBO Robin Swartz sold 6,458 shares at $3.77 per share, all on February 24, 2026.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet